{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:36:55Z","timestamp":1773283015396,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Gujarat State Biotechnology Mission","award":["GSBTM\/MD\/PROJECTS\/SSA\/3386\/2012-13"],"award-info":[{"award-number":["GSBTM\/MD\/PROJECTS\/SSA\/3386\/2012-13"]}]},{"name":"Department of Biotechnology (DBT), Government of India","award":["BT\/PR\/11634\/INF\/22\/104\/2008"],"award-info":[{"award-number":["BT\/PR\/11634\/INF\/22\/104\/2008"]}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research (ICMR)","doi-asserted-by":"publisher","award":["80\/845\/2013-ECD-I"],"award-info":[{"award-number":["80\/845\/2013-ECD-I"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research (ICMR)","doi-asserted-by":"publisher","award":["AMR\/49\/11-ECD-I"],"award-info":[{"award-number":["AMR\/49\/11-ECD-I"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research (ICMR)","doi-asserted-by":"publisher","award":["80\/845\/2013-ECD-I"],"award-info":[{"award-number":["80\/845\/2013-ECD-I"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jgaronline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jgar.2017.10.013","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T16:18:29Z","timestamp":1509121109000},"page":"85-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Involvement of topoisomerase mutations and qnr and aac(6\u2032)Ib -cr genes in conferring quinolone resistance to clinical isolates of Vibrio and Shigella spp. from Kolkata, India (1998\u20132009)"],"prefix":"10.1016","volume":"13","author":[{"given":"Kittappa","family":"Vinothkumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaileshkumar R.","family":"Bhalara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneri","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thandavarayan","family":"Ramamurthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swapan Kumar","family":"Niyogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Naresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6817-3261","authenticated-orcid":false,"given":"Ashima Kushwaha","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2017.10.013_bib0005","first-page":"225","article-title":"Antimicrobials & cholera: are we stranded?","volume":"133","author":"Ghosh","year":"2011","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jgar.2017.10.013_bib0010","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1365-3156.2010.02656.x","article-title":"Subtype prevalence, plasmid profiles and growing fluoroquinolone resistance in Shigella from Kolkata, India (2001\u20132007): a hospital-based study","volume":"15","author":"Nandy","year":"2010","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.jgar.2017.10.013_bib0015","first-page":"133","article-title":"Shigellosis","volume":"43","author":"Niyogi","year":"2005","journal-title":"J Microbiol"},{"key":"10.1016\/j.jgar.2017.10.013_bib0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fmicb.2014.00091","article-title":"Vibrio fluvialis: an emerging human pathogen","volume":"5","author":"Ramamurthy","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2017.10.013_bib0025","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3947\/ic.2014.46.4.226","article-title":"Clinical importance and epidemiology of quinolone resistance","volume":"46","author":"Kim","year":"2014","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jgar.2017.10.013_bib0030","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1128\/AAC.46.8.2676-2678.2002","article-title":"Role of active efflux in association with target mutations in fluoroquinolone resistance in clinical isolates of Vibrio cholerae","volume":"46","author":"Baranwal","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2017.10.013_bib0035","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/jac\/dkp087","article-title":"Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China","volume":"63","author":"Pu","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2017.10.013_bib0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fmicb.2016.00146","article-title":"Characterization of Vibrio fluvialis qnrVC5 gene in native and heterologous hosts: synergy of qnrVC5 with other determinants in conferring quinolone resistance","volume":"7","author":"Vinothkumar","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2017.10.013_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056477","article-title":"Clinical isolates of Vibrio cholerae O1El Tor Ogawa of 2009 from Kolkata, India: preponderance of SXT element and presence of Haitian ctxB variant","volume":"8","author":"Kutar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2017.10.013_bib0050","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijantimicag.2009.03.020","article-title":"Mechanism of drug resistance in a clinical isolate of Vibrio fluvialis: involvement of multiple plasmids and integrons","volume":"34","author":"Rajpara","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2017.10.013_bib0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1099\/jmm.0.037226-0","article-title":"Clinical isolates of Vibrio fluvialis from Kolkata, India, obtained during 2006: plasmids, the qnr gene and a mutation in gyrase A as mechanisms of multidrug resistance","volume":"61","author":"Singh","year":"2012","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2017.10.013_bib0060","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1128\/AAC.01561-05","article-title":"Mechanism of drug resistance in clonally related clinical isolates of Vibrio fluvialis isolated in Kolkata, India","volume":"50","author":"Srinivasan","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2017.10.013_bib0065","series-title":"Performance standards for antimicrobial susceptibility testing; twentieth informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2010"},{"key":"10.1016\/j.jgar.2017.10.013_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102533","article-title":"Fluoroquinolone resistance mechanisms of Shigella flexneri isolated in Bangladesh","volume":"9","author":"Azmi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2017.10.013_bib0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/0971-5916.154508","article-title":"Enhanced resistance to fluoroquinolones in laboratory-grown mutants & clinical isolates of Shigella due to synergism between efflux pump expression & mutations in quinolone resistance determining region","volume":"141","author":"Taneja","year":"2015","journal-title":"Indian J Med Res"},{"issue":"49","key":"10.1016\/j.jgar.2017.10.013_bib0080","first-page":"2976","article-title":"Genetic characterization of multidrug-resistant, extended-spectrum-\u03b2-lactamase-producing Vibrio cholerae O1 outbreak strains, Mpumalanga, South Africa","volume":"2011","author":"Ismail","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"10.1016\/j.jgar.2017.10.013_bib0085","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1093\/infdis\/jit200","article-title":"Cholera outbreak in South Africa, 2008\u20132009: laboratory analysis of Vibrio cholerae O1 strains","volume":"208","author":"Ismail","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2017.10.013_bib0090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijantimicag.2013.03.004","article-title":"Accumulation of mutations in DNA gyrase and topoisomerase IV genes contributes to fluoroquinolone resistance in Vibrio cholerae O139 strains","volume":"42","author":"Zhou","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2017.10.013_bib0095","first-page":"169","article-title":"Transferable plasmid-mediated quinolone resistance in association with extended-spectrum \u03b2-lactamases and fluoroquinolone-acetylating aminoglycoside-6\u2032-N-acetyltransferase in clinical isolates of Vibrio fluvialis","volume":"38","author":"Chowdhury","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2017.10.013_bib0100","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1128\/AAC.49.4.1660-1661.2005","article-title":"Alteration in GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India","volume":"49","author":"Dutta","year":"2005","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371651730200X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371651730200X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T08:24:25Z","timestamp":1535271865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221371651730200X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":20,"alternative-id":["S221371651730200X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2017.10.013","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of topoisomerase mutations and qnr and aac(6\u2032)Ib-cr genes in conferring quinolone resistance to clinical isolates of Vibrio and Shigella spp. from Kolkata, India (1998\u20132009)","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2017.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}